Skip to content
In English |
En español
Search
DMIST, the Digital Mammographic Imaging Screening Trial, is a research study sponsored by the U.S. National Cancer Institute to compare digital mammography to conventional screen-film mammography.
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Colorectal Cancer Drugs Require Careful Patient Selection
Cetuximab for Advanced Lung Cancer
Past Highlights
DMIST Updates
Information from the NCI Press Office
Digital Mammography Trial Results Announced: Women with Dense Breasts, Women Younger than 50, and Those Who are Perimenopausal May Benefit from Digital Mammograms
(Posted: 09/16/2005) - A new study from the NCI shows that currently available screening methods such as transvaginal ultrasound and testing for a protein biomarker called CA-125, alone or in combination, can detect ovarian cancer but can also produce many false-positive test results, causing needless surgery.
Questions and Answers
;
"Fast Facts": The DMIST Study Results
Digital vs. Film Mammography in the Digital Mammographic Imaging Screening Trial (DMIST): Questions and Answers
(Posted: 09/16/2005) - DMIST showed that, for the entire population of women studied, digital and film mammography had very similar screening accuracy.
"Fast Facts": The DMIST Study Results
(Posted: 09/16/2005) - The Digital Mammographic Screening Trial (DMIST) showed that, for the entire population of women studied, digital and film mammography had very similar screening accuracy.
NCI Home
|
Text-Only Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute